Clinical trials: Mohs Surgery

Mohs Surgery

Study of EB-001 in Facial Scar Reduction

• Completed
• Age: 18 to 75 years
• Phase 2
• Injection or infusion
• Results posted

This study will evaluate the safety and efficacy of EB-001 in improving wound healing and reducing scar formation in patients undergoing Mohs surgery for skin lesions in the forehead area following a single treatment of EB-001…

Trial name

NCT03346902

Testing

EB-001, 0.9% Sodium Chloride Injection

Where

United States

Volunteers

12 people

Sponsor

Bonti, Inc.